Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs


Submitted: January 12, 2016
Accepted: January 12, 2016
Published: January 14, 2016
Abstract Views: 3920
PDF: 2847
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.

Pirozzi Farina, F., & Pischedda, A. (2016). Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs. Archivio Italiano Di Urologia E Andrologia, 87(4), 312–316. https://doi.org/10.4081/aiua.2015.4.312

Downloads

Download data is not yet available.

Citations